Keriette Diario

Ethinylestradiol / Levonorgestrel, the active ingredient in Keriette Diario, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Keriette Diario as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Keriette Diario, a combined oral contraceptive, works within the hormonal reproductive pathway to prevent unintended pregnancy. - Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential. - Management of menstrual cycle irregularities: helps regulate cycle length and reduce heavy bleeding. - Treatment of moderate acne: reduces androgen‑driven skin lesions in women using hormonal regulation.

Keriette Diario may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: transient cranial pain. - Weight gain: slight increase in body weight. - Mood changes: irritability or emotional fluctuations. - Breakthrough bleeding: spotting between periods.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Arterial thrombosis: clot formation in arteries leading to stroke or heart attack. - Hypertension: significant increase in blood pressure. - Liver tumor: benign hepatic adenoma development. - Gallbladder disease: formation of gallstones or inflammation. - Severe allergic reaction: anaphylaxis with rash, swelling, or breathing difficulty.

Before prescribing Keriette Diario, clinicians should consider several safety precautions. - Contraindication in pregnancy: the product must not be used by pregnant women. - Smoking over age 35: avoid use in women who smoke heavily due to increased cardiovascular risk. - Cardiovascular assessment: evaluate history of thromboembolic disorders before initiation. - Blood pressure monitoring: check and control hypertension during therapy. - Hepatic function review: assess liver disease as the drug is metabolized hepatically. - Store at room temperature: keep tablets in the original packaging, protect from moisture and light.

Keriette Diario can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy. - Rifampicin and other strong antibiotics: decrease hormone levels, risking breakthrough ovulation. - St. John's wort: herbal inducer that lowers oral contraceptive plasma concentrations. - HIV protease inhibitors (e.g., ritonavir): may increase hormone exposure and side‑effect risk. - Certain antiretrovirals (e.g., efavirenz): diminish contraceptive reliability.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole): may increase hormone levels, requiring monitoring. - Selective serotonin reuptake inhibitors: possible modest increase in side‑effects. - Antihypertensive drugs (e.g., beta‑blockers): monitor blood pressure changes. - Antiemetics (e.g., metoclopramide): may affect hormone metabolism. - Herbal supplements (e.g., ginseng): potential to alter contraceptive effectiveness.